Monday, April 09, 2007

Tepha Flexes Marketing Muscle

by Sara Calabro
Med Tech Sentinel



FDA today gave the thumbs up to Cambridge, MA-based Tepha, to market its TephaFLEX Absorbable Suture product in the U.S. TephaFLEX is the first device that the privately held firm developed from a new class of biopolymers derived from a recombinant DNA technology licensed from the Massachusetts Institute of Technology.

Through a number of corporate partnerships already established by Tepha – including ones with Aesculap AG, HemCon Medical Technologies, LifeCell Corporation (LIFC), NMT Medical (NMTI) and Tornier — this technology is being applied to a wide array of products such as sutures, surgical meshes for orthopedic and hernia repair, anti-adhesion films, hemostats, intra-cardiac devices, absorbable stents, ligament and tendon repair and replacement devices, embolization agents, and drug delivery systems.

The TephaFLEX Absorbable Suture boasts up to 50% greater tensile strength than currently marketed monofilament absorbable sutures. In addition to high strength, the product offers surgeons improved flexibility, good knot security, and prolonged strength retention when implanted.


Source: OneMedPlace.com


____________________

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home

Finance Blogs - Blog Top Sites Day-Traderz Finance Directory blog search directory
Finance Blogs - Blog FlareBlog Directory & Search engine RankingBlogs.com :: Defining Your Blogs Worth: TopSites:
Blog Flux Pinger - reliable ping service.Directory of Investing BlogsBlogarama - The Blog Directory
Blog Directory
Bloggeries Blog Directory Business
Powered by WebRing.